A

Amylyx Pharmaceuticals (AMLX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more

  • 37.02
  • 38.07
  • 36.70
  • 39.78
  • 8.2%
  • 0M
  • 0.00
  • 743.67k
  • 2.6B
  • 6.51
  • %
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.